Your browser doesn't support javascript.
loading
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.
Simonin, Mathieu; Andrieu, Guillaume P; Birsen, Rudy; Balsat, Marie; Hypolite, Guillaume; Courtois, Lucien; Graux, Carlos; Grardel, Nathalie; Cayuela, Jean-Michel; Huguet, Françoise; Chalandon, Yves; Le Bris, Yannick; Macintyre, Elizabeth; Gandemer, Virginie; Petit, Arnaud; Rousselot, Philippe; Baruchel, André; Bouscary, Didier; Hermine, Olivier; Boissel, Nicolas; Asnafi, Vahid.
Afiliação
  • Simonin M; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris Cité, Paris, France.
  • Andrieu GP; Institut Necker-Enfants Malades, INSERM U1151, Paris, France.
  • Birsen R; Department of Pediatric Hematology and Oncology, Assistance Publique-Hôpitaux de Paris, Armand Trousseau Hospital, Sorbonne Université, Paris, France.
  • Balsat M; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris Cité, Paris, France.
  • Hypolite G; Institut Necker-Enfants Malades, INSERM U1151, Paris, France.
  • Courtois L; Department of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France.
  • Graux C; Institut Cochin, INSERM U1016, Paris, France.
  • Grardel N; Hospices Civils de Lyon, Service d'Hématologie Clinique, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Cayuela JM; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris Cité, Paris, France.
  • Huguet F; Institut Necker-Enfants Malades, INSERM U1151, Paris, France.
  • Chalandon Y; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris Cité, Paris, France.
  • Le Bris Y; Institut Necker-Enfants Malades, INSERM U1151, Paris, France.
  • Macintyre E; CHU UCLouvain Namur-Godinne, service d'Hématologie, Yvoir, Belgium.
  • Gandemer V; Laboratory of Hematology, CHRU Lille, Lille, France.
  • Petit A; INSERM U1172, Lille, France.
  • Rousselot P; Laboratory of Hematology and EA3518, Saint-Louis University Hospital, Université de Paris Cité, Paris, France.
  • Baruchel A; Department of Hematology, CHRU-Institut Universitaire de Cancer Toulouse-Oncopole, Toulouse, France.
  • Bouscary D; Division of Hematology, Department of Oncology, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Hermine O; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Boissel N; Hematology Biology, Nantes University Hospital and Nantes-Angers Cancer and Immunology Research Center, Nantes, France.
  • Asnafi V; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris Cité, Paris, France.
Blood ; 141(11): 1353-1358, 2023 03 16.
Article em En | MEDLINE | ID: mdl-36599110
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article